HYHiroto Yamamoto

Hiroto Yamamoto

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Hiroto Yamamoto has a total of 28 co-authors. Here are the top co-authors by number of shared publications:

  • Mochihito Suzuki

    Department of Orthopedic Surgery and Rheumatology Nagoya University Graduate School of Medicine Nagoya Japan

    3 shared publications
  • Chinami Ohnishi

    Department of Orthopedic Surgery and Rheumatology Nagoya University Graduate School of Medicine Nagoya Japan

    2 shared publications
  • Hideshi Sugiura

    Department of Orthopedic Surgery and Rheumatology Nagoya University Graduate School of Medicine Nagoya Japan

    2 shared publications
  • Kaoru Nagai

    Nagoya Garden Clinic Nagoya Japan

    2 shared publications
  • Kenya Terabe

    Department of Orthopedic Surgery and Rheumatology, Nagoya University Graduate School of Medicine , Nagoya

    2 shared publications
  • Mako Nagayoshi

    Department of Preventive Medicine Nagoya University Graduate School of Medicine Nagoya Japan

    2 shared publications

Latest Publications

  • Clinical Characteristics of Sarcopenia Among SARC ‐F‐Negative Patients With Rheumatoid Arthritis

    by Mochihito Suzuki, Shuji Asai, Toshihisa Kojima, Hiroto Yamamoto, Yuki Saito, Yuma Saito, Kenya Terabe, Yoshifumi Ohashi, Kaoru Nagai, Chinami Ohnishi, et al.

    Background: Sarcopenia is clinically important in patients with rheumatoid arthritis (RA) because chronic inflammation and physical dysfunction may contribute to muscle impairment. Although SARC‐F is widely used as a screening tool for sarcopenia, its diagnostic performance in patients with RA remains unclear. This study investigated the agreement between SARC‐F and Asian Working Group for Sarcopenia 2025 (AWGS2025)‐defined sarcopenia and evaluated clinical characteristics of sarcopenia in SARC‐F‐negative patients with RA. Methods: This cross‐sectional study included 212 patients with RA enrolled in a prospective cohort. Sarcopenia was diagnosed according to the AWGS2025 criteria. Agreement between SARC‐F and AWGS2025‐defined sarcopenia was assessed using sensitivity, specificity, overall agreement, and Cohen's kappa coefficient. Multivariable logistic regression and receiver operating characteristic (ROC) curve analyses were performed for SARC‐F‐negative patients. Results: The prevalence of SARC‐F positivity was 10.8%, whereas AWGS2025‐defined sarcopenia was observed in 25.0% of patients. Overall agreement between SARC‐F and AWGS2025‐defined sarcopenia was 72.6%, and Cohen's kappa coefficient was 0.10. Among SARC‐F‐negative patients, 23.3% had sarcopenia. Multivariable logistic regression analysis demonstrated that age and Health Assessment Questionnaire‐Disability Index (HAQ‐DI) were independently associated with sarcopenia. ROC analysis identified an optimal HAQ‐DI cutoff value of 0.25. Patients with sarcopenia showed lower walking speed and prolonged Timed Up and Go performance, despite negative SARC‐F results. Conclusions: Among SARC‐F‐negative patients with RA, a substantial proportion met the AWGS2025 diagnostic criteria for sarcopenia and showed impaired physical performance. These findings indicate that a negative SARC‐F case‐finding result does not necessarily preclude sarcopenia diagnosed according to the AWGS2025 criteria. Trial Registration: UMIN Clinical Trials Registry: UMIN000041034

  • Evaluation of physical function in rheumatoid arthritis patients by locomotive syndrome stage

    by Hiroto Yamamoto, Mochihito Suzuki, Toshihisa Kojima, Takaya Sugiura, Yuki Saito, Yuma Saito, Kenya Terabe, Yoshifumi Ohashi, Ryo Sato, Junya Hasegawa, et al.

    Objectives: The present study aimed to investigate the relationship between locomotive syndrome (LS) and physical function in rheumatoid arthritis (RA) patients. Methods: A total of 324 patients enrolled in a prospective cohort study on frailty in RA patients conducted between 2021 and 2022 were analysed. The 25-question Geriatric Locomotive Function Scale was used to assess LS, defined as stage ≥2 (0: < 7 points; 1: 7–15 points; 2: 16–23 points; 3: ≥24 points). Analysis of variance was used for group comparisons, and receiver operating characteristic analysis for identifying LS-related cut-off values. Results: Mean age was 63 ± 11 years, mean disease duration was 13.1 ± 9.9 years, and 87% of patients were female. The proportion of patients with LS was 38%. Walking speed (odds ratio [OR]: 0.01, 95% confidence interval [CI]: 0.02–0.07), 2-step test (OR: 0.06, 95% CI: 0.01–0.40), and 5 Times Sit-to-Stand (5TSS) test (OR: 1.18, 95% CI: 1.08–1.29) were associated with LS. Cut-off values were 1.21 m/sec for walking speed, 1.2 for 2-step test score, and 10.7 seconds for the 5TSS test. Conclusions: This study clarified the relationship between LS progression and lower limb function in RA patients, and identified cut-off values for LS.

  • Evaluation of Vertebrae in Patients With Ankylosing Spondylitis Using Hounsfield Unit Values

    by Junya Hasegawa, Mochihito Suzuki, Kenji Kishimoto, Ryo Sato, Yusuke Ohno, Takaya Sugiura, Hiroto Yamamoto, Kenya Terabe, Shuji Asai, Shiro Imagama

    Objective: To evaluate vertebral Hounsfield Unit (HU) values on computed tomography (CT) in patients with ankylosing spondylitis (AS) compared to patients without AS and to examine differences in HU values between ankylosed and nonankylosed vertebrae in patients with AS. Methods: This cross‐sectional study included 34 patients with AS and 73 patients without AS who underwent spinal CT between 2004 and 2022. HU values were measured from C3 to L5 in patients with AS and from L1 to L5 in patients without AS. Propensity score (PS) matching based on age and sex was performed to compare HU values between groups. Additionally, HU values were compared between ankylosed and nonankylosed vertebrae within the AS group. Results: After PS matching, vertebral HU values were significantly lower in patients with AS than in patients without AS (136.4 vs. 197.1, p = 0.009). Among patients with AS, HU values were highest in the cervical spine, followed by the thoracic and lumbar regions. Ankylosed vertebrae showed significantly lower HU values than nonankylosed vertebrae across all spinal levels ( p < 0.001). Conclusion: Vertebral HU values were lower in patients with AS compared to age‐ and sex‐matched patients without AS. HU values were highest in the cervical spine, and ankylosed vertebrae consistently exhibited lower HU values than nonankylosed vertebrae across all spinal regions.